vh4004280
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Dec 13, 2021 (NCT05163522)
Timeline
Indications
Studied for
Mechanism of action
- Human immunodeficiency virusINHIBITOR
Human immunodeficiency virus inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06168318 | Phase 1 | Dec 22, 2023 | ViiV Healthcare |
| NCT06039579 | Phase 2 | Oct 25, 2023 | ViiV Healthcare |
| NCT06012136 | Phase 1 | Aug 24, 2023 | ViiV Healthcare |
| NCT05163522 | Phase 1 | Dec 13, 2021 | ViiV Healthcare |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| ViiV Healthcare | For profit | 4 | 4 | 2 | 2021 |
1 organizations
Page 1 / 1